Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response

Clozapine has been consistently shown to be superior to other antipsychotics in the treatment of psychosis. However, clozapine usage has been limited due to required routine blood monitoring and the potential for life threatening side effects. We report a case of a 66-year-old female patient, who de...

Full description

Saved in:
Bibliographic Details
Main Authors: Lila Aboueid, Richard H. McCarthy
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Psychiatry
Online Access:http://dx.doi.org/10.1155/2016/6123913
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548648332820480
author Lila Aboueid
Richard H. McCarthy
author_facet Lila Aboueid
Richard H. McCarthy
author_sort Lila Aboueid
collection DOAJ
description Clozapine has been consistently shown to be superior to other antipsychotics in the treatment of psychosis. However, clozapine usage has been limited due to required routine blood monitoring and the potential for life threatening side effects. We report a case of a 66-year-old female patient, who developed clozapine-induced agranulocytosis after 10 weeks of clozapine treatment and was subsequently successfully treated with a combination of loxapine and cyproheptadine. The combination is thought to mimic the pharmacological profile of clozapine, rendering it as a possible alternative to traditional clozapine treatment.
format Article
id doaj-art-f404443a460d4882941e3ec209644e09
institution Kabale University
issn 2090-682X
2090-6838
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Psychiatry
spelling doaj-art-f404443a460d4882941e3ec209644e092025-02-03T06:13:39ZengWileyCase Reports in Psychiatry2090-682X2090-68382016-01-01201610.1155/2016/61239136123913Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine ResponseLila Aboueid0Richard H. McCarthy1SUNY Downstate Medical Center, Department of Psychiatry, 450 Clarkson Avenue, Brooklyn, NY 11203, USAKingsboro Psychiatric Center, 681 Clarkson Avenue, Brooklyn, NY 11203, USAClozapine has been consistently shown to be superior to other antipsychotics in the treatment of psychosis. However, clozapine usage has been limited due to required routine blood monitoring and the potential for life threatening side effects. We report a case of a 66-year-old female patient, who developed clozapine-induced agranulocytosis after 10 weeks of clozapine treatment and was subsequently successfully treated with a combination of loxapine and cyproheptadine. The combination is thought to mimic the pharmacological profile of clozapine, rendering it as a possible alternative to traditional clozapine treatment.http://dx.doi.org/10.1155/2016/6123913
spellingShingle Lila Aboueid
Richard H. McCarthy
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
Case Reports in Psychiatry
title Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
title_full Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
title_fullStr Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
title_full_unstemmed Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
title_short Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
title_sort loxapine and cyproheptadine combined limit clozapine rebound psychosis and may also predict clozapine response
url http://dx.doi.org/10.1155/2016/6123913
work_keys_str_mv AT lilaaboueid loxapineandcyproheptadinecombinedlimitclozapinereboundpsychosisandmayalsopredictclozapineresponse
AT richardhmccarthy loxapineandcyproheptadinecombinedlimitclozapinereboundpsychosisandmayalsopredictclozapineresponse